New avenues in developmental cancer chemotherapy:
Gespeichert in:
| Format: | Buch |
|---|---|
| Sprache: | English |
| Veröffentlicht: |
Orlando u.a.
Acad. Pr.
1987
|
| Schriftenreihe: | Cancer Symposium <Bristol-Myers Company, <New York, NY>: Bristol-Myers Cancer Symposia
8 |
| Schlagworte: | |
| Beschreibung: | XXX, 528 S. Ill. |
| ISBN: | 0123260205 |
Internformat
MARC
| LEADER | 00000nam a2200000 cb4500 | ||
|---|---|---|---|
| 001 | BV000627528 | ||
| 003 | DE-604 | ||
| 005 | 20070129 | ||
| 007 | t| | ||
| 008 | 870824s1987 xx a||| |||| 00||| eng d | ||
| 020 | |a 0123260205 |9 0-12-326020-5 | ||
| 035 | |a (OCoLC)13945798 | ||
| 035 | |a (DE-599)BVBBV000627528 | ||
| 040 | |a DE-604 |b ger |e rakddb | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-12 |a DE-29 |a DE-355 | ||
| 050 | 0 | |a RC271.C5 | |
| 082 | 0 | |a 616.99/4061 |2 19 | |
| 084 | |a VS 9108 |0 (DE-625)147725:261 |2 rvk | ||
| 084 | |a XH 3212 |0 (DE-625)152888:12918 |2 rvk | ||
| 245 | 1 | 0 | |a New avenues in developmental cancer chemotherapy |c ed. by Kenneth R. Harrap ... |
| 264 | 1 | |a Orlando u.a. |b Acad. Pr. |c 1987 | |
| 300 | |a XXX, 528 S. |b Ill. | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b n |2 rdamedia | ||
| 338 | |b nc |2 rdacarrier | ||
| 490 | 1 | |a Cancer Symposium <Bristol-Myers Company, <New York, NY>: Bristol-Myers Cancer Symposia |v 8 | |
| 650 | 2 | |a Antinéoplasiques - usage thérapeutique | |
| 650 | 7 | |a Farmacotherapie |2 gtt | |
| 650 | 7 | |a Kanker |2 gtt | |
| 650 | 2 | |a Tumeurs - Traitement médicamenteux | |
| 650 | 4 | |a Antineoplastic Agents |x therapeutic use |v Congresses | |
| 650 | 4 | |a Antineoplastic agents |x Testing |v Congresses | |
| 650 | 4 | |a Cancer |x Chemotherapy |x Evaluation |v Congresses | |
| 650 | 4 | |a Neoplasms |x drug therapy |v Congresses | |
| 650 | 0 | 7 | |a Arzneimittelentwicklung |0 (DE-588)4143176-5 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Cytostatikum |0 (DE-588)4068347-3 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Krebs |g Medizin |0 (DE-588)4073781-0 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Bewertung |0 (DE-588)4006340-9 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Chemotherapie |0 (DE-588)4127083-6 |2 gnd |9 rswk-swf |
| 655 | 7 | |0 (DE-588)1071861417 |a Konferenzschrift |y 1985 |z London |2 gnd-content | |
| 689 | 0 | 0 | |a Arzneimittelentwicklung |0 (DE-588)4143176-5 |D s |
| 689 | 0 | 1 | |a Krebs |g Medizin |0 (DE-588)4073781-0 |D s |
| 689 | 0 | |5 DE-604 | |
| 689 | 1 | 0 | |a Chemotherapie |0 (DE-588)4127083-6 |D s |
| 689 | 1 | 1 | |a Bewertung |0 (DE-588)4006340-9 |D s |
| 689 | 1 | 2 | |a Krebs |g Medizin |0 (DE-588)4073781-0 |D s |
| 689 | 1 | |5 DE-604 | |
| 689 | 2 | 0 | |a Cytostatikum |0 (DE-588)4068347-3 |D s |
| 689 | 2 | |5 DE-604 | |
| 700 | 1 | |a Harrap, Kenneth R. |e Sonstige |4 oth | |
| 830 | 0 | |a Cancer Symposium <Bristol-Myers Company, <New York, NY>: Bristol-Myers Cancer Symposia |v 8 |w (DE-604)BV000003966 |9 8 | |
| 943 | 1 | |a oai:aleph.bib-bvb.de:BVB01-000390630 | |
Datensatz im Suchindex
| _version_ | 1823607485334814720 |
|---|---|
| adam_text | |
| any_adam_object | |
| building | Verbundindex |
| bvnumber | BV000627528 |
| callnumber-first | R - Medicine |
| callnumber-label | RC271 |
| callnumber-raw | RC271.C5 |
| callnumber-search | RC271.C5 |
| callnumber-sort | RC 3271 C5 |
| callnumber-subject | RC - Internal Medicine |
| classification_rvk | VS 9108 XH 3212 |
| ctrlnum | (OCoLC)13945798 (DE-599)BVBBV000627528 |
| dewey-full | 616.99/4061 |
| dewey-hundreds | 600 - Technology (Applied sciences) |
| dewey-ones | 616 - Diseases |
| dewey-raw | 616.99/4061 |
| dewey-search | 616.99/4061 |
| dewey-sort | 3616.99 44061 |
| dewey-tens | 610 - Medicine and health |
| discipline | Chemie / Pharmazie Medizin |
| format | Book |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>00000nam a2200000 cb4500</leader><controlfield tag="001">BV000627528</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20070129</controlfield><controlfield tag="007">t|</controlfield><controlfield tag="008">870824s1987 xx a||| |||| 00||| eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">0123260205</subfield><subfield code="9">0-12-326020-5</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)13945798</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV000627528</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rakddb</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-12</subfield><subfield code="a">DE-29</subfield><subfield code="a">DE-355</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">RC271.C5</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">616.99/4061</subfield><subfield code="2">19</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">VS 9108</subfield><subfield code="0">(DE-625)147725:261</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">XH 3212</subfield><subfield code="0">(DE-625)152888:12918</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">New avenues in developmental cancer chemotherapy</subfield><subfield code="c">ed. by Kenneth R. Harrap ...</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Orlando u.a.</subfield><subfield code="b">Acad. Pr.</subfield><subfield code="c">1987</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">XXX, 528 S.</subfield><subfield code="b">Ill.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="1" ind2=" "><subfield code="a">Cancer Symposium <Bristol-Myers Company, <New York, NY>: Bristol-Myers Cancer Symposia</subfield><subfield code="v">8</subfield></datafield><datafield tag="650" ind1=" " ind2="2"><subfield code="a">Antinéoplasiques - usage thérapeutique</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Farmacotherapie</subfield><subfield code="2">gtt</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Kanker</subfield><subfield code="2">gtt</subfield></datafield><datafield tag="650" ind1=" " ind2="2"><subfield code="a">Tumeurs - Traitement médicamenteux</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Antineoplastic Agents</subfield><subfield code="x">therapeutic use</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Antineoplastic agents</subfield><subfield code="x">Testing</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Cancer</subfield><subfield code="x">Chemotherapy</subfield><subfield code="x">Evaluation</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Neoplasms</subfield><subfield code="x">drug therapy</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Arzneimittelentwicklung</subfield><subfield code="0">(DE-588)4143176-5</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Cytostatikum</subfield><subfield code="0">(DE-588)4068347-3</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Krebs</subfield><subfield code="g">Medizin</subfield><subfield code="0">(DE-588)4073781-0</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Bewertung</subfield><subfield code="0">(DE-588)4006340-9</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Chemotherapie</subfield><subfield code="0">(DE-588)4127083-6</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="0">(DE-588)1071861417</subfield><subfield code="a">Konferenzschrift</subfield><subfield code="y">1985</subfield><subfield code="z">London</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Arzneimittelentwicklung</subfield><subfield code="0">(DE-588)4143176-5</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Krebs</subfield><subfield code="g">Medizin</subfield><subfield code="0">(DE-588)4073781-0</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="1" ind2="0"><subfield code="a">Chemotherapie</subfield><subfield code="0">(DE-588)4127083-6</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2="1"><subfield code="a">Bewertung</subfield><subfield code="0">(DE-588)4006340-9</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2="2"><subfield code="a">Krebs</subfield><subfield code="g">Medizin</subfield><subfield code="0">(DE-588)4073781-0</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="2" ind2="0"><subfield code="a">Cytostatikum</subfield><subfield code="0">(DE-588)4068347-3</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="2" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Harrap, Kenneth R.</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="830" ind1=" " ind2="0"><subfield code="a">Cancer Symposium <Bristol-Myers Company, <New York, NY>: Bristol-Myers Cancer Symposia</subfield><subfield code="v">8</subfield><subfield code="w">(DE-604)BV000003966</subfield><subfield code="9">8</subfield></datafield><datafield tag="943" ind1="1" ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-000390630</subfield></datafield></record></collection> |
| genre | (DE-588)1071861417 Konferenzschrift 1985 London gnd-content |
| genre_facet | Konferenzschrift 1985 London |
| id | DE-604.BV000627528 |
| illustrated | Illustrated |
| indexdate | 2025-02-09T19:00:21Z |
| institution | BVB |
| isbn | 0123260205 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-000390630 |
| oclc_num | 13945798 |
| open_access_boolean | |
| owner | DE-12 DE-29 DE-355 DE-BY-UBR |
| owner_facet | DE-12 DE-29 DE-355 DE-BY-UBR |
| physical | XXX, 528 S. Ill. |
| publishDate | 1987 |
| publishDateSearch | 1987 |
| publishDateSort | 1987 |
| publisher | Acad. Pr. |
| record_format | marc |
| series | Cancer Symposium <Bristol-Myers Company, <New York, NY>: Bristol-Myers Cancer Symposia |
| series2 | Cancer Symposium <Bristol-Myers Company, <New York, NY>: Bristol-Myers Cancer Symposia |
| spelling | New avenues in developmental cancer chemotherapy ed. by Kenneth R. Harrap ... Orlando u.a. Acad. Pr. 1987 XXX, 528 S. Ill. txt rdacontent n rdamedia nc rdacarrier Cancer Symposium <Bristol-Myers Company, <New York, NY>: Bristol-Myers Cancer Symposia 8 Antinéoplasiques - usage thérapeutique Farmacotherapie gtt Kanker gtt Tumeurs - Traitement médicamenteux Antineoplastic Agents therapeutic use Congresses Antineoplastic agents Testing Congresses Cancer Chemotherapy Evaluation Congresses Neoplasms drug therapy Congresses Arzneimittelentwicklung (DE-588)4143176-5 gnd rswk-swf Cytostatikum (DE-588)4068347-3 gnd rswk-swf Krebs Medizin (DE-588)4073781-0 gnd rswk-swf Bewertung (DE-588)4006340-9 gnd rswk-swf Chemotherapie (DE-588)4127083-6 gnd rswk-swf (DE-588)1071861417 Konferenzschrift 1985 London gnd-content Arzneimittelentwicklung (DE-588)4143176-5 s Krebs Medizin (DE-588)4073781-0 s DE-604 Chemotherapie (DE-588)4127083-6 s Bewertung (DE-588)4006340-9 s Cytostatikum (DE-588)4068347-3 s Harrap, Kenneth R. Sonstige oth Cancer Symposium <Bristol-Myers Company, <New York, NY>: Bristol-Myers Cancer Symposia 8 (DE-604)BV000003966 8 |
| spellingShingle | New avenues in developmental cancer chemotherapy Cancer Symposium <Bristol-Myers Company, <New York, NY>: Bristol-Myers Cancer Symposia Antinéoplasiques - usage thérapeutique Farmacotherapie gtt Kanker gtt Tumeurs - Traitement médicamenteux Antineoplastic Agents therapeutic use Congresses Antineoplastic agents Testing Congresses Cancer Chemotherapy Evaluation Congresses Neoplasms drug therapy Congresses Arzneimittelentwicklung (DE-588)4143176-5 gnd Cytostatikum (DE-588)4068347-3 gnd Krebs Medizin (DE-588)4073781-0 gnd Bewertung (DE-588)4006340-9 gnd Chemotherapie (DE-588)4127083-6 gnd |
| subject_GND | (DE-588)4143176-5 (DE-588)4068347-3 (DE-588)4073781-0 (DE-588)4006340-9 (DE-588)4127083-6 (DE-588)1071861417 |
| title | New avenues in developmental cancer chemotherapy |
| title_auth | New avenues in developmental cancer chemotherapy |
| title_exact_search | New avenues in developmental cancer chemotherapy |
| title_full | New avenues in developmental cancer chemotherapy ed. by Kenneth R. Harrap ... |
| title_fullStr | New avenues in developmental cancer chemotherapy ed. by Kenneth R. Harrap ... |
| title_full_unstemmed | New avenues in developmental cancer chemotherapy ed. by Kenneth R. Harrap ... |
| title_short | New avenues in developmental cancer chemotherapy |
| title_sort | new avenues in developmental cancer chemotherapy |
| topic | Antinéoplasiques - usage thérapeutique Farmacotherapie gtt Kanker gtt Tumeurs - Traitement médicamenteux Antineoplastic Agents therapeutic use Congresses Antineoplastic agents Testing Congresses Cancer Chemotherapy Evaluation Congresses Neoplasms drug therapy Congresses Arzneimittelentwicklung (DE-588)4143176-5 gnd Cytostatikum (DE-588)4068347-3 gnd Krebs Medizin (DE-588)4073781-0 gnd Bewertung (DE-588)4006340-9 gnd Chemotherapie (DE-588)4127083-6 gnd |
| topic_facet | Antinéoplasiques - usage thérapeutique Farmacotherapie Kanker Tumeurs - Traitement médicamenteux Antineoplastic Agents therapeutic use Congresses Antineoplastic agents Testing Congresses Cancer Chemotherapy Evaluation Congresses Neoplasms drug therapy Congresses Arzneimittelentwicklung Cytostatikum Krebs Medizin Bewertung Chemotherapie Konferenzschrift 1985 London |
| volume_link | (DE-604)BV000003966 |
| work_keys_str_mv | AT harrapkennethr newavenuesindevelopmentalcancerchemotherapy |